SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-012301
Filing Date
2023-04-10
Accepted
2023-04-10 16:20:26
Documents
6
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A labp_pre_14a_4.10.23.htm PRE 14A 1196149
2 GRAPHIC img129734205_0.jpg GRAPHIC 37873
3 GRAPHIC img129734205_1.jpg GRAPHIC 3038
4 GRAPHIC img129734205_2.jpg GRAPHIC 3038
5 GRAPHIC img129734205_3.jpg GRAPHIC 576156
6 GRAPHIC img129734205_4.jpg GRAPHIC 188633
  Complete submission text file 0000950170-23-012301.txt   2307107
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39971 | Film No.: 23811365
SIC: 2834 Pharmaceutical Preparations